Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Buy
56
MELI Quote, Financials, Valuation and Earnings
Last price:
$1,834.13
Seasonality move
:
8.74%
Day range:
$1,815.06 - $1,851.39
52-week range:
$1,324.99 - $2,161.73
Dividend yield:
0%
P/E ratio:
64.83x
P/S ratio:
5.09x
P/B ratio:
23.27x
Volume:
239.8K
Avg. volume:
386.4K
1-year change:
9.84%
Market cap:
$93.1B
Revenue:
$14.5B
EPS (TTM):
$28.34
Analysts' Opinion
-
Consensus RatingMercadoLibre has received a consensus rating of Buy. The company's average rating is a Buy based on 13 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $2,252.05, MercadoLibre has an estimated upside of 22.58% from its current price of $1,837.18.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1,750.00 representing 4.75% downside risk from its current price of $1,837.18.
Fair Value
-
According to the consensus of 17 analysts, MercadoLibre has 22.58% upside to fair value with a price target of $2,252.05 per share.
MELI vs. S&P 500
-
Over the past 5 trading days, MercadoLibre has overperformed the S&P 500 by 3.68% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
MercadoLibre does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
MercadoLibre has grown year-over-year revenues for 0 quarters straight. In the most recent quarter MercadoLibre reported revenues of $5.3B.
Earnings Growth
-
MercadoLibre has grown year-over-year earnings for 3 quarters straight. In the most recent quarter MercadoLibre reported earnings per share of $7.83.
Enterprise value:
95.1B
EV / Invested capital:
--
Price / LTM sales:
5.09x
EV / EBIT:
42.13x
EV / Revenue:
5.14x
PEG ratio (5yr expected):
1.44x
EV / Free cash flow:
15.37x
Price / Operating cash flow:
15.23x
Enterprise value / EBITDA:
33.28x
Gross Profit (TTM):
$8.5B
Return On Assets:
7.53%
Net Income Margin (TTM):
7.77%
Return On Equity:
42.62%
Return On Invested Capital:
18.08%
Operating Margin:
10.49%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $9.7B | $13.7B | $18.5B | $3.9B | $5.3B | |
| Gross Profit | $4.6B | $7B | $8.5B | $2.1B | $2.4B | |
| Operating Income | $709M | $2.2B | $1.8B | $785M | $557M | |
| EBITDA | $1.1B | $2.4B | $2.9B | $719M | $717M | |
| Diluted EPS | $5.37 | $19.54 | $28.34 | $7.16 | $7.83 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.9B | $5.3B | $9.4B | $13.1B | $17.8B | |
| Total Assets | $5.7B | $6.8B | $12B | $16.1B | $22.6B | |
| Current Liabilities | $3B | $4.3B | $7B | $10.3B | $14.3B | |
| Total Liabilities | $3.9B | $6.7B | $10.3B | $13.4B | $18.6B | |
| Total Equity | $1.8B | $123M | $1.6B | $2.7B | $4B | |
| Total Debt | $1.2B | $2.7B | $4.6B | $4.4B | $5.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.1B | $4.8B | $6.9B | $941M | $1.6B | |
| Cash From Investing | -$3.9B | -$3.2B | -$7.1B | -$1.3B | -$2.6B | |
| Cash From Financing | $3.2B | -$352M | $1.3B | $132M | $726M | |
| Free Cash Flow | $1.6B | $4.3B | $6.2B | $815M | $1.4B | |
MELI
Sector
Market Cap
$93.1B
$464.6M
Price % of 52-Week High
84.99%
71.71%
Dividend Yield
0%
0%
Shareholder Yield
-0.1%
3.59%
1-Year Price Total Return
9.84%
-10.38%
Beta (5-Year)
1.604
0.958
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$1,779.67
200-day SMA
Buy
Level
$1,801.68
Bollinger Bands (100)
Sell
Level
1831.91 - 2086.41
Chaikin Money Flow
Buy
Level
61.1M
20-day SMA
Buy
Level
$1,755.10
Relative Strength Index (RSI14)
Buy
Level
53.74
ADX Line
Buy
Level
22.75
Williams %R
Sell
Level
-8.972
50-day SMA
Sell
Level
$1,870.77
MACD (12, 26)
Sell
Level
-19.90
25-day Aroon Oscillator
Sell
Level
-24
On Balance Volume
Neutral
Level
111.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.8158)
Sell
CA Score
(Annual)
Level (-1.1272)
Buy
Beneish M-Score
(Annual)
Level (-3.3418)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (0.6109)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
MercadoLibre runs the largest e-commerce marketplace in Latin America, with more than 218 million active users and 1 million active sellers across 18 countries stitching into its commerce network or fintech solutions as of the end of 2023. The company operates a host of complementary businesses to its core online shop, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago and Mercado Credito), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Stock Forecast FAQ
In the current month, MELI has received 13 Buy ratings 4 Hold ratings, and 0 Sell ratings. The MELI average analyst price target in the past 3 months is $2,252.05.
-
Where Will MercadoLibre Stock Be In 1 Year?
According to analysts, the consensus estimate is that MercadoLibre share price will rise to $2,252.05 per share over the next 12 months.
-
What Do Analysts Say About MercadoLibre?
Analysts are divided on their view about MercadoLibre share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MercadoLibre is a Sell and believe this share price will drop from its current level to $1,750.00.
-
What Is MercadoLibre's Price Target?
The price target for MercadoLibre over the next 1-year time period is forecast to be $2,252.05 according to 17 Wall Street analysts, 13 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is MELI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for MercadoLibre is a Buy. 13 of 17 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MELI?
You can purchase shares of MercadoLibre via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MercadoLibre shares.
-
What Is The MercadoLibre Share Price Today?
MercadoLibre was last trading at $1,834.13 per share. This represents the most recent stock quote for MercadoLibre. Yesterday, MercadoLibre closed at $1,837.18 per share.
-
How To Buy MercadoLibre Stock Online?
In order to purchase MercadoLibre stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will T-Mobile Stock Recover?
Last year was a stellar year for telecom giant T-Mobile…
Why Is Stanley Druckenmiller Buying Citigroup?
As recently as 2020, few analysts could have predicted that…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 112x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
NUTX alert for Jan 17
Nutex Health [NUTX] is up 2.83% over the past day.
Buy
53
QMCO alert for Jan 17
Quantum [QMCO] is down 15.61% over the past day.
Sell
34
NGVT alert for Jan 17
Ingevity [NGVT] is up 1.31% over the past day.
